BDKRB1 and glioblastoma: In our previous work in anti-GBM–induced experimental nephritis mice, blockade of the B2R bradykinin receptor worsened disease whereas blockade of B1R ameliorated disease [15], once again suggesting the pro-inflammatory and pathogenic role of the B1R in immune-mediated nephritis.